Edgewise Therapeutics, Inc. (EWTX)
44.22
-0.50
(-1.12%)
USD |
NASDAQ |
Aug 25, 16:00
44.22
0.00 (0.00%)
After-Hours: 19:22
Edgewise Therapeutics Price to Book Value : 10.64 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 10.76 |
| August 21, 2026 | 10.63 |
| August 20, 2026 | 10.41 |
| August 19, 2026 | 11.17 |
| August 18, 2026 | 10.61 |
| August 17, 2026 | 10.59 |
| August 14, 2026 | 10.62 |
| August 13, 2026 | 10.39 |
| August 12, 2026 | 10.48 |
| August 11, 2026 | 10.66 |
| August 10, 2026 | 10.72 |
| August 07, 2026 | 10.47 |
| August 06, 2026 | 10.68 |
| August 05, 2026 | 10.82 |
| August 04, 2026 | 10.75 |
| August 03, 2026 | 9.232 |
| July 31, 2026 | 9.244 |
| July 30, 2026 | 9.891 |
| July 29, 2026 | 9.561 |
| July 28, 2026 | 9.705 |
| July 27, 2026 | 10.01 |
| July 24, 2026 | 9.823 |
| July 23, 2026 | 9.450 |
| July 22, 2026 | 9.220 |
| July 21, 2026 | 9.520 |
| Date | Value |
|---|---|
| July 20, 2026 | 9.335 |
| July 17, 2026 | 9.564 |
| July 16, 2026 | 9.186 |
| July 15, 2026 | 9.821 |
| July 14, 2026 | 9.556 |
| July 13, 2026 | 9.927 |
| July 10, 2026 | 10.92 |
| July 09, 2026 | 11.63 |
| July 08, 2026 | 11.14 |
| July 07, 2026 | 10.37 |
| July 06, 2026 | 9.645 |
| July 02, 2026 | 9.515 |
| July 01, 2026 | 9.417 |
| June 30, 2026 | 9.773 |
| June 29, 2026 | 8.918 |
| June 26, 2026 | 9.035 |
| June 25, 2026 | 9.085 |
| June 24, 2026 | 9.218 |
| June 23, 2026 | 8.462 |
| June 22, 2026 | 7.954 |
| June 18, 2026 | 8.022 |
| June 17, 2026 | 7.588 |
| June 16, 2026 | 7.399 |
| June 15, 2026 | 7.673 |
| June 12, 2026 | 7.590 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 14.99 |
| CNBX Pharmaceuticals, Inc. | -- |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 1.115 |
| Fulcrum Therapeutics, Inc. | 0.9465 |
Price to Book Value Related Metrics
| PEG Ratio | -1.267 |
| Price | 44.22 |
| Earnings Yield | -4.18% |
| Market Cap | 4.766B |
| PEGY Ratio | -1.267 |